Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria

Urology

Volumn 58, Issue 3, 2001, Pages 417-424

  Bartsch, Georg ^a   Horninger, Wolfgang ^a   Klocker, Helmut ^a   Reissigl, Andreas ^a   Oberaigner, Wilhelm ^b   Schönitzer, Dieter ^c   Severi, Gianluca ^d   Robertson, Chris ^d   Boyle, Peter ^d  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Cancer Registry of Tyrol   (Austria)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; AUSTRIA; CANCER MORTALITY; CANCER SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; ATTITUDE TO HEALTH; AUSTRIA; FEES AND CHARGES; HEALTH POLICY; HEALTH PROMOTION; HUMANS; MALE; MASS MEDIA; MASS SCREENING; MIDDLE AGED; MORTALITY; POISSON DISTRIBUTION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS;

EID: 0034860041     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)01264-X     Document Type: Article

References (30)

1. Patterns of care for carcinoma of the prostate gland; results of a national survey of 1984 and 1990
2. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer; results of a multicenter clinical trial of 6,630 men
3. The pathological features and prognosis of prostate cancer detectable with current diagnostic tests
4. The nature of prostate cancer detected through prostate specific antigen based screening
5. Screening for prostate cancer; an analysis of the early experience
6. Comparison of different PSA cutpoints for early detection of prostate cancer; results of a large screening study
7. PSA based screening for prostate cancer in asymptomatic younger males; pilot study in blood donors
8. Frequency and clinical significance of transition zone cancer in prostate cancer screening
9. Usefulness of the ratio free/total PSA in addition to total PSA levels in prostate cancer screening
10. Improvement of specificity in PSA based screening by using PSA transition zone density and percent free PSA in addition to total PSA levels
11. Serum prostate specific antigen in a community-based population of healthy men; establishment of age specific reference ranges
12. Prostate carcinoma screening in the federal state of Tyrol, Austria
13. Epidemiology of chemoprevention of prostate cancer
14. Measurement of prostate specific antigen in serum as a screening test for prostate cancer
15. The results of prostate carcinoma screening in the U.S. as reflected in the Surveillance, Epidemiology, and End Results Program
16. Cancer surveillance series; interpreting trends in prostate cancer-part I: evidence of the effects of screening in recent prostate cancer incidence, mortality and survival rates
17. Cancer surveillance series; interpreting trends in prostate cancer-part II: cause of death misclassification and the recent rise and fall in prostate cancer mortality
18. Cancer surveillance series; interpreting trends in prostate cancer-part III: quantifying link between population prostate specific antigen testing and recent declines in prostate cancer mortality
19. Screening digital rectal examination and prostate cancer mortality; a population-based case-control study
20. Prostate specific antigen (PSA) testing as screening for prostate cancer; the current controversy
21. Trends in mortality from cervical cancer in the Nordic countries; association with organised screening programs
22. Reduction in breast cancer mortality due to the introduction of mass screening in The Netherlands; comparison with the United Kingdom
23. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer